MBX MBX Biosciences, Inc.
$50.29▲ +3.69%
Healthcare
Other
Volume 653.0K
Avg Volume (10D) 678.1K
Key Metrics & Fundamentals
Market Cap
$2.42B
P/E Ratio
–
Div Yield
0.00%
52W Range
16.95 - 72.64
% vs 50 MA
-14.56%
% vs 200 MA
11.19%
RSI-14
40.6
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.03
Free Cash Flow
-$23.52M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$40.85M
COGS
–
Operating Exp
$40.93M
Operating Income
-$40.93M
EBIT
-$40.93M
Pretax Income
-$37.10M
Net Income
-$37.10M
EPS (Diluted)
-0.78
Price & Volume History
Loading chart…
Recent News
MBX Biosciences to Participate in Upcoming November Investor Conferences
GlobeNewswire · Oct 13, 2026 8:00 AM ET
Is MBX Biosciences (MBX) Still Undervalued After Its Pullback From A Strong 1 Year Run?
Simply Wall St. · Oct 10, 2026 12:19 AM ET
MBX Biosciences (MBX) Stock Could Be Above Fair Value As Shares Jumped 257%
Simply Wall St. · Oct 9, 2026 8:18 PM ET
MBX Biosciences to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 9, 2026 8:00 AM ET
MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer
GlobeNewswire · Sep 8, 2026 8:00 AM ET
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
GlobeNewswire · Aug 27, 2026 8:00 AM ET
UMH Properties and 4 More Stocks See Action From Activist Investors
Barrons.com · Aug 14, 2026 7:05 PM ET
Truist Adjusts Price Target on MBX Biosciences to $88 From $70, Maintains Buy Rating
MT Newswires · Aug 10, 2026 6:11 AM ET
MBX Biosciences Shares Lower After Q2 Loss Widens
MT Newswires · Aug 6, 2026 10:40 AM ET
MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights
GlobeNewswire · Aug 6, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MBX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.